The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Brief Report
PreviousPrevious
Volume 358:2030-2038 May 8, 2008 Number 19
NextNext

An Immunodeficiency Disease with RAG Mutations and Granulomas
Catharina Schuetz, M.D., Kirsten Huck, M.D., Sonja Gudowius, M.D., Mosaad Megahed, M.D., Oliver Feyen, Ph.D., Bernd Hubner, Ph.D., Dominik T. Schneider, M.D., Burkhard Manfras, M.D., Ulrich Pannicke, Ph.D., Rein Willemze, M.D., Ruth Knüchel, M.D., Ulrich Göbel, M.D., Ansgar Schulz, M.D., Arndt Borkhardt, M.D., Wilhelm Friedrich, M.D., Klaus Schwarz, M.D., and Tim Niehues, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-PowerPoint Slide Set
-Supplementary Material

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
SUMMARY

We describe three unrelated girls who had an immunodeficiency disease with granulomas in the skin, mucous membranes, and internal organs. All three girls had severe complications after viral infections, including B-cell lymphoma associated with Epstein–Barr virus (EBV). Other findings were hypogammaglobulinemia, a diminished number of T and B cells, and sparse thymic tissue on ultrasonography. Molecular analysis revealed that the patients were compound heterozygotes for mutations in recombination activating gene 1 or 2 (RAG1 or RAG2). In each case, both parents were heterozygous carriers of a RAG mutation. The mutations were associated with reduced function of RAG in vitro (3 to 30% of normal activity). The parents and one sibling in the three families were healthy.


Source Information

From the Departments of Pediatrics and Adolescent Medicine (C.S., A.S., W.F.) and Internal Medicine (B.M.) and the Institute for Transfusion Medicine (U.P.), University Hospital Ulm, and the Institute for Clinical Transfusion Medicine and Immunogenetics (K.S.) — all in Ulm; the Department of Pediatric Oncology, Hematology, and Clinical Immunology, Children's Hospital, Universitäts Klinikum Düsseldorf, Heinrich Heine University, Düsseldorf (K.H., S.G., O.F., B.H., D.T.S., U.G., A.B., T.N.); and the Departments of Pathology (R.K.) and Dermatology (M.M.), University Hospital Aachen, Aachen — all in Germany; and the Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands (R.W.).

Address reprint requests to Dr. Niehues at the Center for Child and Adolescent Health, HELIOS Klinikum Krefeld, Academic Hospital, Heinrich Heine University of Düsseldorf, Lutherpl. 40, 47805 Krefeld, Germany, or at tim.niehues{at}helios-kliniken.de.

Full Text of this Article




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.